MYGN
Price
$5.60
Change
-$0.03 (-0.53%)
Updated
Jul 3 closing price
Capitalization
1.93B
27 days until earnings call
PFGTF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
41.1M
Interact to see
Advertisement

MYGN vs PFGTF

Header iconMYGN vs PFGTF Comparison
Open Charts MYGN vs PFGTFBanner chart's image
Myriad Genetics
Price$5.60
Change-$0.03 (-0.53%)
Volume$463.76K
Capitalization1.93B
Pacific Edge
Price$0.06
Change-$0.00 (-0.00%)
Volume$80K
Capitalization41.1M
MYGN vs PFGTF Comparison Chart in %
Loading...
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFGTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYGN vs. PFGTF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYGN is a Buy and PFGTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (MYGN: $5.60 vs. PFGTF: $0.06)
Brand notoriety: MYGN and PFGTF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MYGN: 19% vs. PFGTF: 183%
Market capitalization -- MYGN: $1.93B vs. PFGTF: $41.1M
MYGN [@Medical Specialties] is valued at $1.93B. PFGTF’s [@Medical Specialties] market capitalization is $41.1M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYGN’s FA Score shows that 1 FA rating(s) are green whilePFGTF’s FA Score has 0 green FA rating(s).

  • MYGN’s FA Score: 1 green, 4 red.
  • PFGTF’s FA Score: 0 green, 5 red.
According to our system of comparison, both MYGN and PFGTF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYGN’s TA Score shows that 5 TA indicator(s) are bullish while PFGTF’s TA Score has 0 bullish TA indicator(s).

  • MYGN’s TA Score: 5 bullish, 3 bearish.
  • PFGTF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, MYGN is a better buy in the short-term than PFGTF.

Price Growth

MYGN (@Medical Specialties) experienced а +5.07% price change this week, while PFGTF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

MYGN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MYGN($1.93B) has a higher market cap than PFGTF($41.1M). PFGTF YTD gains are higher at: 1.466 vs. MYGN (-59.154). PFGTF has higher annual earnings (EBITDA): -16.55M vs. MYGN (-197.4M). MYGN has more cash in the bank: 141M vs. PFGTF (23.1M). PFGTF has less debt than MYGN: PFGTF (2.88M) vs MYGN (152M). MYGN has higher revenues than PFGTF: MYGN (753M) vs PFGTF (7.7M).
MYGNPFGTFMYGN / PFGTF
Capitalization1.93B41.1M4,689%
EBITDA-197.4M-16.55M1,193%
Gain YTD-59.1541.466-4,036%
P/E RatioN/AN/A-
Revenue753M7.7M9,778%
Total Cash141M23.1M610%
Total Debt152M2.88M5,281%
FUNDAMENTALS RATINGS
MYGN vs PFGTF: Fundamental Ratings
MYGN
PFGTF
OUTLOOK RATING
1..100
1646
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
6559
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFGTF's Valuation (38) in the null industry is somewhat better than the same rating for MYGN (97) in the Biotechnology industry. This means that PFGTF’s stock grew somewhat faster than MYGN’s over the last 12 months.

PFGTF's Profit vs Risk Rating (100) in the null industry is in the same range as MYGN (100) in the Biotechnology industry. This means that PFGTF’s stock grew similarly to MYGN’s over the last 12 months.

MYGN's SMR Rating (93) in the Biotechnology industry is in the same range as PFGTF (97) in the null industry. This means that MYGN’s stock grew similarly to PFGTF’s over the last 12 months.

PFGTF's Price Growth Rating (59) in the null industry is in the same range as MYGN (65) in the Biotechnology industry. This means that PFGTF’s stock grew similarly to MYGN’s over the last 12 months.

MYGN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for PFGTF (100) in the null industry. This means that MYGN’s stock grew significantly faster than PFGTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MYGNPFGTF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
81%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 3 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
MYGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFGTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCMIX159.192.28
+1.45%
Columbia Seligman Tech & Info Inst2
CCRIX25.420.31
+1.23%
Columbia Small Cap Growth R
ILVBX10.430.08
+0.77%
Columbia Integrated Large Cap Val A
TSFCX12.770.08
+0.63%
Touchstone Small Cap C
LEXCX66.810.15
+0.23%
Voya Corporate Leaders Trust B

MYGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYGN has been loosely correlated with WAT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MYGN jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYGN
1D Price
Change %
MYGN100%
-0.53%
WAT - MYGN
39%
Loosely correlated
-0.48%
GMED - MYGN
37%
Loosely correlated
-2.31%
EMBC - MYGN
33%
Poorly correlated
+0.68%
VCYT - MYGN
31%
Poorly correlated
-0.25%
AORT - MYGN
31%
Poorly correlated
-0.42%
More

PFGTF and

Correlation & Price change

A.I.dvisor tells us that PFGTF and RSLS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PFGTF and RSLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFGTF
1D Price
Change %
PFGTF100%
N/A
RSLS - PFGTF
29%
Poorly correlated
-2.07%
FDMDF - PFGTF
28%
Poorly correlated
N/A
RCEL - PFGTF
26%
Poorly correlated
+4.84%
LIVN - PFGTF
25%
Poorly correlated
+0.11%
MYGN - PFGTF
20%
Poorly correlated
-0.53%
More